Superior Group Q2: Sales Up 2.6%, Adjusted EBITDA Jumps 26%, but $2.6M Impairment Hits Healthcare Apparel
SGC sits 63% above its 52-week low of $8.3 on elevated volume (2.1× avg).
Summary
Superior Group's Q2 results showed top-line growth and strong EBITDA expansion, but a $2.6 million impairment in Healthcare Apparel and new tariff risks temper the outlook. CEO Benstock's new contract extends his tenure to 2029.
Key Events · Earnings and Guidance · SGC
-
Q2 Revenue and Profit Growth
Net sales rose 2.6% to $147.8M; net income was $1.2M ($0.08/share). Adjusted EBITDA jumped 26% to $7.7M, driven by Branded Products.
-
$2.6M Tradename Impairment
Healthcare Apparel segment recorded a $2.6M impairment on CID Resources trade names, reflecting lower expected future sales and profitability.
-
CEO Employment Agreement Extended
New agreement with CEO Michael Benstock extends term to May 2029, with $1.04M base salary, guaranteed $500K annual bonus, and a $2.1M retention bonus upon retirement.
-
Tariff Refunds and New Tariff Risks
Company recorded $4.3M in tariff refunds ($3.1M received in cash). New tariffs of 10-12.5% under Section 301 took effect July 24, 2026, potentially pressuring future costs.
Analysis · SGC · Manufacturing
A solid quarter for Superior Group saw net sales climb 2.6% to $147.8 million and adjusted EBITDA surge 26% to $7.7 million, powered by momentum in Branded Products. Yet a $2.6 million tradename impairment charge in the Healthcare Apparel segment erased most of that unit's profit, underscoring persistent headwinds. In a vote of confidence, the board locked in CEO Michael Benstock through 2029 with a new employment agreement featuring a $1.04 million base salary and a $2.1 million retention bonus. Tariff refunds of $4.3 million provided a lift, though new tariffs effective July 24, 2026, could squeeze future margins. The balance sheet remains manageable with $22.8 million in cash and full compliance with debt covenants.
At the time of this filing, SGC was trading at $13.50 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $202M. The 52-week trading range was $8.30 to $14.59. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.